Clinical outcomes and differential effects of PI3K pathway mutation in obese versus non-obese patients with cervical cancer

This publication has 25 references indexed in Scilit:

• Association of cancer mortality with postdiagnosis overweight and obesity using body mass index
  Oncotarget, 2015
• AKT Inhibitors Promote Cell Death in Cervical Cancer through Disruption of mTOR Signaling and Glucose Uptake
  PLOS ONE, 2014
• Pathway-Specific Analysis of Gene Expression Data Identifies the PI3K/Akt Pathway as a Novel Therapeutic Target in Cervical Cancer
  Clinical Cancer Research, 2012
• Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study
  BMJ, 2007
• The standardized uptake value for F‐18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival
  Cancer, 2007
• Rare cancer-specific mutations in PIK3CA show gain of function
  Proceedings of the National Academy of Sciences, 2007
• Cancer-specific mutations in PIK3CA are oncogenic in vivo
  Proceedings of the National Academy of Sciences, 2006
• The oncogenic properties of mutant p110α and p110β phosphatidylinositol 3-kinases in human mammary epithelial cells
  Proceedings of the National Academy of Sciences, 2005
• Breast Cancer–Associated PIK3CA Mutations Are Oncogenic in Mammary Epithelial Cells
  Cancer Research, 2005
• Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults
  New England Journal of Medicine, 2003